Friday, 21 January, 2022
TopicVaccine patent

Topic: Vaccine patent

G7 focus on China a breather for Modi’s India. But questions on Covid drugs won’t go away

Jyoti Malhotra -
G7 diplomats are now echoing the Supreme Court of India — why hasn't the Modi govt granted compulsory licences to pharma companies to at least manufacture anti-Covid drugs if not vaccines.

No time to lose, conclude talks on vaccines patent waiver by July-end: India to WTO

PTI -
India along with 61 co-sponsors submitted a revised proposal in May on TRIPS waiver for all WTO members regarding prevention, containment, and treatment of Covid.

BRICS with a Capital C: How Covid robbed members of economic advantage

Seshadri Chari -
Vaccine manufacturers China and Russia never came forward to share the formula with or waive IPR for other BRICS members. So much for the cooperation in the Covid fight.

Covid vaccine patents can be waived without hurting firms like Bharat Biotech. Here’s how

Jagdish Shettigar -
It is time countries acted with a humanitarian approach at WTO and relaxed IPR provisions for Covid-19 vaccines. And it can be done without disincentivising R&D efforts.

India’s vaccine diplomacy is falling apart. Why PM Modi can’t convince EU to waive patents

Jyoti Malhotra -
While Modi waxed eloquent on India-EU trade talks, European leaders were unhappy at US for supporting Delhi's demand to waive Covid vaccine patents.

Why the TRIPS waiver is unlikely to solve India’s Covid-19 vaccine shortage

Shivangi Mittal -
Instead of trying to obtain an IP waiver, the govt must enable vaccine manufacturers to expand production & reduce inefficiencies in procurement & distribution.

With ‘Gandhi’ and ‘Nehru’ in his cabinet, Stalin has a historical burden to shake off

ThePrint Team -
ThePrint view on the most important issues, instantly.

Now, it’s over to the WTO to clinch a deal on vaccine patent waivers

Bryce Baschuk -
India and South Africa have proposed a broad waiver from the Trips agreement’s rules on the production and export of vaccines needed to combat the Covid-19 virus.

Now is not the time to hanker for patents. WTO must waive IP rights on Covid vaccines

Arvind Mayaram -
US, EU, Canada and other developed nations, with access to Covid-19 vaccines, must stop opposing India and South Africa's proposal to waive patent and intellectual property rights.

On Camera

YourTurn

Opinion

How Facebook and Amazon rely on an invisible workforce

Parmy Olson -
The market for on-demand, digital tasks is estimated by the World Bank to be worth $25 billion, with Meta Platforms, Amazon, YouTube as some of the biggest buyers.
Representational image of a Covid vaccine | Bloomberg

One shot vaccine to protect against all Covid variants is within reach. Here’s how to grab it

Representative image of domestic violence

Men on ‘marriage strike’ against marital rape laws. Some people laugh, say good riddance

Economy

Representational image of a jewellery store | ANI

India Jewellery Park to be set up in Mumbai, aims to attract Rs 20,000 crore investment

Pia Krishnankutty -
The Gem & Jewellery Export Promotion Council and Maharashtra Industrial Development Corporation have signed a draft agreement granting possession of a plot for setting up the park.

Defence

Foreign secretary Harsh Vardhan Shringla meets German Navy chief Vice Admiral Kay-Achim Schönbach on 20 January. | Twitter | @MEAIndia

New chapter in ties as Indian foreign secy meets Germany navy chief, warship ‘Bayern’ visits

Nayanima Basu -
With Germany identifying India as one of the key partners in its Indo-Pacific policy, a German frigate entered Indian waters for a port call in Mumbai, in a major signal to China.

National Interest

Illustration by Soham Sen | ThePrint

Read my lips, I’m hurting, says Pakistan’s National Security Policy. What it means for India

Shekhar Gupta -
The new policy is mostly chaff, but it reveals the most inward-looking Pakistan in 3 decades. It needs breathing space, and is realising loss of stature and friendship with US.

Follow us

Copyright © 2022 Printline Media Pvt. Ltd. All rights reserved.

×